---
title: OM1 at ISPE Annual 2026
description: >-
  OM1 is exhibiting and presenting research at the 42nd ISPE Annual Meeting! Our
  team would love to meet with you to talk about how OM1’s solutions can help
  unlock the power of pharmacoepidemiology to improve patient outcomes.
category: Page
canonical_url: https://www.om1.com/ispe-annual-2026/
source: om1
license: © 2026 OM1. All rights reserved.
slug: ispe-annual-2026
id: 54zO6FwcbzSUwRyhCk3ci4
contentType: page
---

# OM1 at ISPE Annual 2026

**August 29 - September 2 | Milan, Italy | Booth #205**

OM1 is exhibiting and presenting research at the 42nd ISPE Annual Meeting! Our team would love to meet with you to talk about how OM1’s solutions can help unlock the power of pharmacoepidemiology to improve patient outcomes.

*Scroll down for more information about our research being presented at the conference.*

![Collage 2x2 Shapes Color](https://images.ctfassets.net/ddhe5ahaolzf/3b935vCREqq9MhCAFKv9W0/06b77bc0965a9b245f6d9edff47846d7/collage-2x2-shapes-color.jpg)


- [Meet with Us at ISPE](#form) 

## OM1 Research at ISPE Annual 2026

### Risk of Mild Cognitive Impairment or Alzheimer’s Disease after Bumetanide Initiation: A New-User, Active-Comparator, Cohort Study

**Podium**

- Wednesday, September 2, 9:45 to 10:00 am
- Podium 5G-06
- Presented by Chandrasekar Gopalakrishnan, Senior Principal Epidemiologist, OM1.



### Use of AI-powered Methods to Extract and Categorize Reasons for Treatment Changes in Real-World Care Settings in Mental Health, Immunology, and Rheumatology

**Poster**

- Monday, August 31, 12:00 to 1:30 pm
- Poster A-036



### Validation of the Systemic Immune-Inflammation Index (SII) as a Biomarker for Disease Activity in Rheumatoid Arthritis: A Real-World Study

**Poster**

- Wednesday, September 2, 12:00 to 1:30 pm
- Poster C-275